Patents by Inventor Sergei B. Onikienko

Sergei B. Onikienko has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9937241
    Abstract: The present invention relates to novel therapies that utilize stabilized exogenous HSP70 for the treatment of disorders or conditions regulated by HSP70 through administration of degradation resistant formulations of HSP70. Furthermore, the present invention is directed to methods comprising the administration of stabilized exogenous HSP70 for use in the treatment of HSP70 related disorders or conditions, for example, for increased endurance or alleviating fatigue syndrome.
    Type: Grant
    Filed: October 13, 2012
    Date of Patent: April 10, 2018
    Assignee: ALTERNATIVE INNOVATIVE TECHNOLOGIES LLC
    Inventors: Sergei B Onikienko, Alex Nivorozhkin
  • Patent number: 9616100
    Abstract: The present invention relates to novel therapies that utilize exogenous HSP70 for the treatment of disorders or conditions regulated by HSP70 through administration of exogenous HSP70.
    Type: Grant
    Filed: July 16, 2014
    Date of Patent: April 11, 2017
    Assignee: ALTERNATIVE INNOVATIVE TECHNOLOGIES LLC
    Inventors: Sergei B Onikienko, Alex Nivorozhkin, Alexander V Zemlyanoi
  • Patent number: 9217018
    Abstract: The present invention relates to novel therapies that utilize HSP70 fusion proteins for the treatment of disorders or conditions regulated by HSP70.
    Type: Grant
    Filed: December 15, 2012
    Date of Patent: December 22, 2015
    Inventors: Sergei B Onikienko, Alex Nivorozhkin, Alexander V Zemlyanoi, Mikhail Viktorovich Shorokhov, Vladimir Ivanovich Pereguda, Valery Aleksandrovich Chereshnev
  • Publication number: 20140329764
    Abstract: The present invention relates to novel therapies that utilize exogenous HSP70 for the treatment of disorders or conditions regulated by HSP70 through administration of exogenous HSP70.
    Type: Application
    Filed: July 16, 2014
    Publication date: November 6, 2014
    Applicant: Alternative Innovative Technologies LLC
    Inventors: Sergei B. Onikienko, Alex Nivorozhkin, Alexander V. Zemlyanoi
  • Publication number: 20130156694
    Abstract: The present invention relates to novel therapies that utilize HSP70 fusion proteins for the treatment of disorders or conditions regulated by HSP70.
    Type: Application
    Filed: December 15, 2012
    Publication date: June 20, 2013
    Applicant: ALTERNATIVE INNOVATIVE TECHNOLOGIES LLC
    Inventors: Sergei B. Onikienko, Alex Nivorozhkin, Alexander V. Zemlyanoi, Mikhail Viktorovich Shorokhov, Vladimir Ivanovich Pereguda, Valery Aleksandrovich Chereshnev
  • Publication number: 20130101573
    Abstract: The present invention relates to novel therapies that utilize stabilized exogenous HSP70 for the treatment of disorders or conditions regulated by HSP70 through administration of degradation resistant formulations of HSP70.
    Type: Application
    Filed: October 13, 2012
    Publication date: April 25, 2013
    Applicant: Alternative Innovative Technologies LLC
    Inventors: Sergei B. Onikienko, Alex Nivorozhkin
  • Publication number: 20130090294
    Abstract: The present invention relates to novel therapies that utilize exogenous HSP70 for the treatment of disorders or conditions regulated by HSP70 through administration of exogenous HSP70.
    Type: Application
    Filed: June 28, 2012
    Publication date: April 11, 2013
    Applicant: ALTERNATIVE INNOVATIVE TECHNOLOGIES LLC
    Inventors: Sergei B. Onikienko, Alex Nivorozhkin, Alexander V. Zemlyanoi